We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+10%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$44.5B
AUM Growth
-$1.18B
Cap. Flow
-$4.15B
Cap. Flow %
-9.34%
Top 10 Hldgs %
9.83%
Holding
3,927
New
652
Increased
690
Reduced
847
Closed
1,056

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$309M
2
XOM icon
ExxonMobil
XOM
+$302M
3
AMZN icon
Amazon
AMZN
+$291M
4
C icon
Citigroup
C
+$253M
5
SHOP icon
Shopify
SHOP
+$238M

Top Sells

Rank Stock Value
1
HUM icon
Humana
HUM
+$383M
2
JNJ icon
Johnson & Johnson
JNJ
+$312M
3
JPM icon
JPMorgan Chase
JPM
+$285M
4
T icon
AT&T
T
+$191M
5
DG icon
Dollar General
DG
+$187M

Sector Composition

Rank Sector Weight
1 Healthcare 15.63%
2 Financials 15.61%
3 Technology 14.28%
4 Consumer Discretionary 13.21%
5 Industrials 5.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SCLE
3751
DELISTED
Broadscale Acquisition Corp. Class A common stock
SCLE
-1,570,668
Closed -$15.5M
SHACW
3752
CALL
DELISTED
SCP & CO Healthcare Acquisition Company Warrant
SHACW
-443,917
Closed -$4.38M
SHAC
3753
DELISTED
SCP & CO Healthcare Acquisition Company Class A Common Stock
SHAC
-1,103,054
Closed -$10.9M
VTIQ
3754
DELISTED
VectoIQ Acquisition Corp. II Class A Common Stock
VTIQ
-851,831
Closed -$8.41M
VTIQW
3755
CALL
DELISTED
VectoIQ Acquisition Corp. II Warrant
VTIQW
-20,000
Closed -$196K
KAHC.WS
3756
CALL
DELISTED
KKR Acquisition Holdings I Corp. Redeemable Warrants, each whole Warrant exercisable for one share of Class A Common Stock, each at an exercise price of $11.50 per share
KAHC.WS
-749,871
Closed -$7.38M
FTCVW
3757
CALL
DELISTED
FinTech Acquisition Corp. V Warrant
FTCVW
-300,000
Closed -$2.99M
CLIM
3758
DELISTED
Climate Real Impact Solutions II Acquisition Corporation
CLIM
-752,679
Closed -$7.42M
OEPW
3759
DELISTED
One Equity Partners Open Water I Corp. Class A Common Stock
OEPW
-1,645,982
Closed -$16.2M
AFAC
3760
DELISTED
Arena Fortify Acquisition Corp. Class A Common Stock
AFAC
-298,503
Closed -$3M
OEPWW
3761
CALL
DELISTED
One Equity Partners Open Water I Corp. Warrant
OEPWW
-337,881
Closed -$3.33M
ZWRK
3762
DELISTED
Z-Work Acquisition Corp. Class A Common Stock
ZWRK
-1,058,489
Closed -$10.5M
ZWRKW
3763
CALL
DELISTED
Z-Work Acquisition Corp. Warrant
ZWRKW
-114,695
Closed -$1.15M
FSSI
3764
DELISTED
Fortistar Sustainable Solutions Corp. Class A Common Stock
FSSI
-652,034
Closed -$6.45M
FSSIW
3765
CALL
DELISTED
Fortistar Sustainable Solutions Corp. Warrant
FSSIW
-384,997
Closed -$3.81M
CLRM
3766
DELISTED
Clarim Acquisition Corp. Class A Common Stock
CLRM
-1,368,859
Closed -$13.5M
CLRMW
3767
CALL
DELISTED
Clarim Acquisition Corp. Warrant
CLRMW
-431,013
Closed -$4.26M
HTPA
3768
DELISTED
Highland Transcend Partners I Corp.
HTPA
-1,374,795
Closed -$13.7M
MACC
3769
DELISTED
Mission Advancement Corp.
MACC
-1,609,629
Closed -$15.8M
RACB
3770
DELISTED
Research Alliance Corp. II Class A Common Stock
RACB
-593,542
Closed -$5.83M
REVH
3771
DELISTED
Revolution Healthcare Acquisition Corp. SAIL Class A Common Stock
REVH
-2,260,399
Closed -$22.2M
SWCH
3772
DELISTED
Switch, Inc. Class A Common Stock
SWCH
-136,600
Closed -$4.6M
NDACW
3773
CALL
DELISTED
NightDragon Acquisition Corp. Warrants to purchase Class A common stock
NDACW
-98,311
Closed -$965K
NDAC
3774
DELISTED
NightDragon Acquisition Corp. Class A Common stock
NDAC
-1,566,523
Closed -$15.4M
AKUS
3775
DELISTED
Akouos Inc
AKUS
-820,934
Closed -$5.55M

Similar funds

Marshall Wace's Q4 2022 Portfolio in Review

As of Q4 2022, Marshall Wace held 3,927 positions worth $44.5B, down 2.6% from $45.6B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.

Marshall Wace withdrew a net $4.15B in Q4 2022, closing 1,056 positions and reducing 847 holdings. Its most notable exit was Humana, an estimated $383M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Financials and Technology.

Against the trend, Marshall Wace opened a new position in Elevance Health worth $188M.

  • Marshall Wace's largest Q4 2022 buy was Elevance Health: 366,649 shares worth $188M.
  • Marshall Wace added most to Biogen in Q4 2022, an estimated $309M increase.
  • Marshall Wace's biggest Q4 2022 reduction was Johnson & Johnson, cutting an estimated $312M.
  • Marshall Wace fully exited Humana in Q4 2022, selling an estimated $383M.
  • Marshall Wace's ten largest holdings make up 9.8% of its $44.5B portfolio in Q4 2022.
  • Marshall Wace opened 652 new positions and closed 1,056 in Q4 2022.
  • Marshall Wace's portfolio value fell 2.6% quarter-over-quarter to $44.5B.

Based on Marshall Wace's 13F filing for Q4 2022, filed 14 Feb 2023.